Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Recommendation of "Moderate Buy" by Brokerages

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $93.33.

PBH has been the subject of several research analyst reports. DA Davidson raised their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Raymond James upgraded shares of Prestige Consumer Healthcare to a "moderate buy" rating in a report on Thursday, December 19th. Oppenheimer increased their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research report on Thursday, February 13th. Royal Bank of Canada lifted their price target on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a report on Friday, March 21st. Finally, StockNews.com downgraded Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th.

Prestige Consumer Healthcare Stock Up 0.4 %

Prestige Consumer Healthcare stock traded up $0.30 during midday trading on Friday, hitting $80.10. 292,350 shares of the stock were exchanged, compared to its average volume of 286,506. Prestige Consumer Healthcare has a 52-week low of $62.35 and a 52-week high of $90.04. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The business's 50-day moving average price is $84.27 and its 200-day moving average price is $80.03. The stock has a market capitalization of $3.97 billion, a price-to-earnings ratio of 18.76, a price-to-earnings-growth ratio of 2.69 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, research analysts expect that Prestige Consumer Healthcare will post 4.5 EPS for the current fiscal year.

Insider Activity at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now owns 17,157 shares of the company's stock, valued at $1,544,130. The trade was a 8.91 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Large investors have recently modified their holdings of the company. Kestra Investment Management LLC bought a new position in Prestige Consumer Healthcare in the 4th quarter valued at $27,000. CIBC Private Wealth Group LLC grew its position in Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after buying an additional 152 shares in the last quarter. Opal Wealth Advisors LLC bought a new position in Prestige Consumer Healthcare in the 1st quarter worth about $38,000. Headlands Technologies LLC purchased a new stake in shares of Prestige Consumer Healthcare in the 4th quarter valued at about $40,000. Finally, McIlrath & Eck LLC grew its holdings in shares of Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock worth $75,000 after purchasing an additional 154 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.